© 1983 Oxford University Press
research-article |
Mutagenicity Of Chloropropanol In A Genetic Screening Battery
Exxon Corporation East Millstone, New Jersey AHazleton Laboratories Vienna, Virginia
Mutagenicity Of Chloropropanol In A Genetic Screening Battery. Biles, R.W. and Piper, C.E. (1983). Fundam. Appl. Toxicol. 3:3734. A 72:25 mixture of l-chloro-2-propanol and 2-chloro-l-propanol was tested for genetic activity in a battery of short term tests. Chloropropanol was tested over a dose range of 527167, 250 µg/plate in the Salmonella/mammalian microsome mutagenicity assay. A dose dependent mutagenic response was observed in strains TA 1535 and TA 100. Metabolic activation enhanced mutagenicity in both strains. Although chloropropanol was mutagenic in the TK+/ mouse lymphoma assay with and without metabolic activation, a smooth linear dose response relationship was not observed. Non-toxic mutagenic doses ranged from 5,000 to 10,000 µg/mL without activation. Chloropropanol was also mutagenic in the rat bone marrow cytogenetic assay. Rats dosed orally with 10,31 and 100 mg/kg/day for 5 days displayed no significant difference in mean body weight gain or mean mitotic index when compared to controls, however, a dose-response increase (significant) in the number of aberrations, mostly chromatid breaks, was observed in each case.